Published in Arch Surg on September 01, 1992
Osteosarcoma follow-up: chest X-ray or computed tomography? Clin Sarcoma Res (2017) 1.39
The Current and Future Therapies for Human Osteosarcoma. Curr Cancer Ther Rev (2013) 0.79
Osteosarcoma relapse as pleural metastasis. South Asian J Cancer (2013) 0.77
Hepatic metastatic disease in pediatric and adolescent solid tumors. World J Hepatol (2015) 0.75
Ifosfamide/etoposide alternating with high-dose methotrexate: evaluation of a chemotherapy regimen for poor-risk osteosarcoma. Br J Cancer (1999) 0.75
HIV evolution: CTL escape mutation and reversion after transmission. Nat Med (2004) 10.21
Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol (1993) 8.07
Recombination within natural populations of pathogenic bacteria: short-term empirical estimates and long-term phylogenetic consequences. Proc Natl Acad Sci U S A (2001) 7.90
Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J Exp Med (2001) 6.51
Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J Virol (1993) 6.41
The epidemic behavior of the hepatitis C virus. Science (2001) 4.81
Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. J Clin Oncol (1992) 3.86
Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer (1982) 3.82
Impaired immunologic reactivity and recurrence following cancer surgery. Cancer (1970) 3.77
Evolutionary aspects of recombination in RNA viruses. J Gen Virol (1999) 3.74
Population dynamics of flaviviruses revealed by molecular phylogenies. Proc Natl Acad Sci U S A (1996) 3.69
Demonstration of antibodies against human malignant melanoma by immunofluorescence. Surgery (1968) 3.56
Extinction rates can be estimated from molecular phylogenies. Philos Trans R Soc Lond B Biol Sci (1994) 3.47
Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol (1992) 3.37
Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. J Gen Virol (1993) 2.87
Leiomyosarcoma of the inferior vena cava: prognosis and comparison with leiomyosarcoma of other anatomic sites. Cancer (1999) 2.81
Cross-protective immunity can account for the alternating epidemic pattern of dengue virus serotypes circulating in Bangkok. Proc Natl Acad Sci U S A (2006) 2.77
Extinction and rapid emergence of strains of dengue 3 virus during an interepidemic period. Virology (2002) 2.53
Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS-5 regions. J Gen Virol (1994) 2.53
Ecology and evolution of rabies virus in Europe. J Gen Virol (1999) 2.52
Causes of HIV diversity. Nature (1995) 2.48
Immunological factors which influence response to immunotherapy in malignant melanoma. Surgery (1970) 2.34
Inferring population history from molecular phylogenies. Philos Trans R Soc Lond B Biol Sci (1995) 2.21
Human immunodeficiency virus. Phylogeny and the origin of HIV-1. Nature (2001) 2.20
A likelihood method for the detection of selection and recombination using nucleotide sequences. Mol Biol Evol (1997) 2.20
Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas. J Clin Oncol (2001) 2.20
Public health: then and now. The first neighborhood health center movement--its rise and fall. Am J Public Health (1971) 2.19
Investigation of potential HIV transmission to the patients of an HIV-infected surgeon. JAMA (1993) 2.17
BCG immunotherapy of malignant melanoma: summary of a seven-year experience. Ann Surg (1974) 2.14
Widespread intra-serotype recombination in natural populations of dengue virus. Proc Natl Acad Sci U S A (1999) 2.12
Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery. Cancer (1979) 2.11
Networks and groups within the genus Neisseria: analysis of argF, recA, rho, and 16S rRNA sequences from human Neisseria species. Mol Biol Evol (1999) 2.10
The role of MCM proteins in the cell cycle control of genome duplication. Bioessays (1996) 2.09
Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection, and prosthetic bone replacement. Arch Pathol Lab Med (1977) 2.06
The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial. J Thorac Cardiovasc Surg (1991) 2.06
Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. The International HCV Collaborative Study Group. J Gen Virol (1995) 2.00
Depression and somatization: a review. Part I. Am J Med (1982) 2.00
Chemotherapy, en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma. Cancer (1976) 1.97
Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic features. Cancer (1994) 1.95
Parathyroid carcinoma: a collective review. Ann Surg (1969) 1.94
Genealogical evidence for positive selection in the nef gene of HIV-1. Genetics (1999) 1.93
A rational approach to the surgical management of melanoma. Ann Surg (1977) 1.88
Secondary structure of the 3' untranslated region of flaviviruses: similarities and differences. Nucleic Acids Res (1997) 1.84
Synovial sarcoma. Uniform response of metastases to high dose ifosfamide. Cancer (1994) 1.84
A multigene analysis of the phylogenetic relationships among the flaviviruses (Family: Flaviviridae) and the evolution of vector transmission. Arch Virol (2005) 1.72
Immunological factors in human sarcomas and melanomas: a rational basis for immunotherapy. Ann Surg (1970) 1.68
Complete sequence of two tick-borne flaviviruses isolated from Siberia and the UK: analysis and significance of the 5' and 3'-UTRs. Virus Res (1997) 1.63
Molecular epidemiology of dengue virus type 3 in Venezuela. J Gen Virol (2003) 1.61
Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial. J Clin Oncol (1987) 1.59
Epidemic dynamics revealed in dengue evolution. Mol Biol Evol (2009) 1.58
The molecular evolution of the alcohol dehydrogenase and alcohol dehydrogenase-related genes in the Drosophila melanogaster species subgroup. Mol Biol Evol (1994) 1.58
Adjuvant immunotherapy with BCG in treatment of regional-lymph-node metastases from malignant melanoma. N Engl J Med (1976) 1.57
Etiology and results of tumor endoprosthesis revision surgery in 64 patients. Clin Orthop Relat Res (1999) 1.56
Phylogenetic relationships among rhabdoviruses inferred using the L polymerase gene. J Gen Virol (2005) 1.55
Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin. Lancet (1995) 1.54
The rationale for planned reoperation after unplanned total excision of soft-tissue sarcomas. J Clin Oncol (1985) 1.54
Influence of methotrexate dose intensity on outcome of patients with high grade osteogenic osteosarcoma. Analysis of the literature. Cancer (1996) 1.51
Genetic diversity of Borrelia burgdorferi sensu lato in ticks from mainland Portugal. J Clin Microbiol (2000) 1.50
In vivo distribution and cytopathology of variants of human immunodeficiency virus type 1 showing restricted sequence variability in the V3 loop. J Virol (1994) 1.50
Mesenchymal chondrosarcoma. A clinicopathologic analysis of 35 patients with emphasis on treatment. Cancer (1983) 1.49
Molecular epidemiology of dengue type 2 virus in Venezuela: evidence for in situ virus evolution and recombination. J Gen Virol (2001) 1.48
Specificity and sensitivity of the assay for elastin-derived peptides in chronic obstructive pulmonary disease. Am Rev Respir Dis (1992) 1.48
Survival, prognosis, and therapeutic response in osteogenic sarcoma. The Memorial Hospital experience. Cancer (1992) 1.47
Is amputation necessary for sarcomas? A seven-year experience with limb salvage. Ann Surg (1980) 1.46
Evolutionary analysis of variants of hepatitis C virus found in South-East Asia: comparison with classifications based upon sequence similarity. J Gen Virol (1996) 1.46
Radiographic changes in primary osteogenic sarcoma following intensive chemotherapy. Radiological-pathological correlation in 63 patients. Radiology (1982) 1.46
Surgical resection and intraperitoneal chemotherapy for recurrent abdominal sarcomas. Ann Surg Oncol (1999) 1.46
Head and neck sarcoma: report of the Head and Neck Sarcoma Registry. Society of Head and Neck Surgeons Committee on Research. Head Neck (1992) 1.46
Prosthetic replacement of the inferior vena cava for malignancy. J Vasc Surg (1998) 1.45
A reevaluation of the higher taxonomy of viruses based on RNA polymerases. J Virol (1996) 1.44
High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma. Cancer (1974) 1.44
Population dynamics of HIV-1 inferred from gene sequences. Genetics (1999) 1.43
The role of adjuvant radiotherapy in the treatment of resectable desmoid tumors. Int J Radiat Oncol Biol Phys (1997) 1.42
Hemifacial spasm associated with external carotid artery compression of the facial nerve. J Laryngol Otol (1996) 1.40
Retroperitoneal sarcomas: a reappraisal of treatment. J Surg Oncol (1981) 1.40
A slaughter of innocents: aspects of child health in the 18th-century city. Stud Eighteenth Cent Cult (1976) 1.39
Health is a community affair. A bookshelf compiled from the reports of the National Task Forces project. Am J Public Health Nations Health (1967) 1.39
A bookshelf on poverty and health. Am J Public Health Nations Health (1969) 1.39
A phylogenetic survey of recombination frequency in plant RNA viruses. Arch Virol (2005) 1.39
The indications for polysomnography and related procedures. Sleep (1997) 1.38
Mother-to-child transmission of HIV infection and CTL escape through HLA-A2-SLYNTVATL epitope sequence variation. Immunol Lett (2001) 1.37
Expression patterns of immediate early transcription factors in human non-small cell lung cancer. The Lung Cancer Study Group. Oncogene (1995) 1.34
Genetic analysis of Israel acute paralysis virus: distinct clusters are circulating in the United States. J Virol (2008) 1.34
Smoking behavior following diagnosis in patients with stage I non-small cell lung cancer. Cancer Causes Control (1991) 1.34
Neurofibrosarcoma. Cancer (1980) 1.33
Specialization in public health. Am J Public Health (1972) 1.33
Variable immune-driven natural selection in the attachment (G) glycoprotein of respiratory syncytial virus (RSV). J Mol Evol (2001) 1.32
Phase I clinical trial of taxotere administered as either a 2-hour or 6-hour intravenous infusion. J Clin Oncol (1993) 1.32
Proceedings: Disease-free survival in children with Ewing's sarcoma treated with radiation therapy and adjuvant four-drug sequential chemotherapy. Cancer (1974) 1.31
Evidence for the non-quasispecies evolution of RNA viruses [corrected]. Mol Biol Evol (2001) 1.31
Secondary structure of the 3'-untranslated region of yellow fever virus: implications for virulence, attenuation and vaccine development. J Gen Virol (1997) 1.28
The American Journal of Public Health: antecedents, origin and evolution. Am J Public Health (1972) 1.28
Advances in the treatment of sarcomas of the extremity. Current status of limb salvage. Cancer (1984) 1.28
Pharmacological criteria for ventricular assist device insertion following postcardiotomy shock: experience with the Abiomed BVS system. J Card Surg (2000) 1.28
Immunologic studies of human sarcomas: Additional evidence suggesting an associated sarcoma virus. Cancer (1970) 1.27